Author:
Berger Gregor E,Wood Stephen J,Wellard R Mark,Proffitt Tina M,McConchie Mirabel,Amminger G Paul,Jackson Graeme D,Velakoulis Dennis,Pantelis Christos,McGorry Patrick D
Publisher
Springer Science and Business Media LLC
Subject
Psychiatry and Mental health,Pharmacology
Reference86 articles.
1. Abbott C, Bustillo J (2006). What have we learned from proton magnetic resonance spectroscopy about schizophrenia? A critical update. Curr Opin Psychiatry 19: 135–139.
2. Amminger GP, Schaefer MR, Papageorgiou K, Becker J, Mossaheb N, Harrigan S et al (2007). Omega-3 fatty acids reduce the risk of early transition to psychosis in ultra-high risk individuals: a double-blind randomized, placebo-controlled treatment study. International Conference of Schizophrenia Research (ICOSR), Colorado.
3. Arvindakshan M, Ghate M, Ranjekar PK, Evans DR, Mahadik SP (2003). Supplementation with a combination of omega-3 fatty acids and antioxidants (vitamins E and C) improves the outcome of schizophrenia. Schizophr Res 62: 195–204.
4. Bazan NG (2005). Lipid signaling in neural plasticity, brain repair, and neuroprotection. Mol Neurobiol 32: 89–103.
5. Bazan NG, Packard MG, Teather L, Allan G (1997). Bioactive lipids in excitatory neurotransmission and neuronal plasticity. Neurochem Int 30: 225–231.
Cited by
109 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献